WallStreetZen

AnalystsAndrew Berens
Andrew Berens's Stock Forecasts

Analyst Ranking
Bottom 1%
#3503 out of 3525 analysts
Average Return
-11.39%
Win Rate
33%25 out of 75
Risk vs Reward
Poor
Good

Andrew Berens's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Blueprint Medicines CorpBPMC
+130.14%$35.87$82.55
2017-02-14 -
2018-02-15
Strong Buy
Zentalis Pharmaceuticals IncZNTL
+67.39%$35.57$59.54
2020-04-27 -
2021-04-28
Buy
Blueprint Medicines CorpBPMC
+64.43%$60.13$98.87
2020-04-28 -
2021-04-29
Buy
Zentalis Pharmaceuticals IncZNTL
+60.78%$45.66$73.41
2021-04-12 -
2021-12-01
Buy
Agios Pharmaceuticals IncAGIO
+40.36%$33.80$47.44
2020-12-08 -
2021-02-26
Buy

Andrew Berens's Stock Coverage

Name / Ticker# of RatingsRatingPrice TargetUpside/DownsideActionDate
Aura Biosciences IncAURA
1Buy$40.00+120.87%Initiates Coverage On
10 days ago
Agios Pharmaceuticals IncAGIO
4Hold$42.00+19.86%Maintains
14 days ago
Forma Therapeutics Holdings IncFMTX
4Buy$40.00+194.12%Maintains
20 days ago
HOOKIPA Pharma IncHOOK
1Buy$10.00+224.68%Maintains
22 days ago
Zymeworks IncZYME
5Hold$27.00+33.40%Maintains
23 days ago
Theseus Pharmaceuticals IncTHRX
1Buy$28.00+83.13%Initiates Coverage On
a month ago
Nurix Therapeutics IncNRIX
2Buy$64.00+125.27%Maintains
a month ago
Seagen IncSGEN
13Buy$200.00+26.38%Maintains
a month ago
Arvinas IncARVN
1Buy$115.00+51.66%Initiates Coverage On
2 months ago
C4 Therapeutics IncCCCC
1Buy$67.00+94.82%Initiates Coverage On
2 months ago
Monte Rosa Therapeutics IncGLUE
1Hold$20.00+14.88%Initiates Coverage On
2 months ago
BeiGene LtdBGNE
3Buy$414.00+17.62%Maintains
2 months ago
Merus NVMRUS
2Buy$45.00+79.64%Maintains
2 months ago
Astrazeneca PlcAZN
6Buy$73.00+33.02%Maintains
2 months ago
Incyte CorpINCY
6Hold$66.00+1.60%Upgrades
2 months ago
Mirati Therapeutics IncMRTX
2Buy$205.00+55.26%Maintains
2 months ago
Tango Therapeutics IncTNGX
1Buy$25.00+150.00%Initiates Coverage On
2 months ago
Elevation Oncology IncELEV
1Buy$20.00+168.46%Initiates Coverage On
4 months ago
Blueprint Medicines CorpBPMC
7Buy$137.00+42.66%Maintains
6 months ago
Cullinan Oncology IncCGEM
2Buy$54.00+226.09%Maintains
6 months ago
Epizyme IncEPZM
4Buy$16.00+447.01%Upgrades
7 months ago
Viracta Therapeutics IncVIRX
1Buy$18.00+337.96%Initiates Coverage On
7 months ago
Global Blood Therapeutics IncGBT
1Buy$54.00+99.04%Initiates Coverage On
8 months ago
Zentalis Pharmaceuticals IncZNTL
2Buy$64.00-12.82%Maintains
8 months ago
Aveo Pharmaceuticals IncAVEO
2Buy$18.00+204.05%Maintains
9 months ago
Deciphera Pharmaceuticals IncDCPH
3Buy$70.00+775.00%Upgrades
10 months ago
Cogent Biosciences IncCOGT
1Buy$20.00+166.31%Initiates Coverage On
a year ago
Turning Point Therapeutics IncTPTX
3Buy$127.00+248.23%Maintains
a year ago
Clovis Oncology IncCLVS
2Sell$5.00N/ADowngrades
2 years ago
Nabriva Therapeutics plcNBRV
2Strong Buy$8.00N/AReinstates
3 years ago
TESARO IncTSRO
2Strong Buy$146.00N/AMaintains
4 years ago
Intercept Pharmaceuticals IncICPT
1Strong Sell$50.00N/AMaintains
4 years ago
Ocular Therapeutix IncOCUL
2Hold$8.00N/AMaintains
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.